M H Rubenstein|T J Harrist - JoVE Visualize

Showing results (51-60 of 64) with videos related to

Pageof 7

Sort By:

The Journal of Investigative Dermatology|November 1, 1983

Lymphocyte subsets and Langerhans cells/indeterminate cells in erythema multiformeR J Margolis, M G Tonnesen, T J Harrist, et al.

American Journal of Clinical Pathology|March 1, 1983

Histiocytosis-X: in situ characterization of cutaneous infiltrates with monoclonal antibodiesT J Harrist, A K Bhan, G F Murphy, et al.

The Journal of Investigative Dermatology|May 1, 1995

Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiformeL F Brown, T J Harrist, K T Yeo, et al.

Circulation|January 11, 2000

Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?M H Rubenstein, L C Harrell, B V Sheynberg, et al.

The American Journal of Cardiology|March 29, 2001

Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failureM H Rubenstein, B V Sheynberg, L C Harrell, et al.

JAMA|September 3, 1982

Skin lesions suspected to be melanoma should be photographed. Gross morphological features of primary melanoma associated with metastasesC L Day, M C Mihm, A J Sober, et al.

Archives of Dermatology|March 1, 1984

Linear IgA bullous dermatosis v dermatitis herpetiformis. Quantitative measurements of dermoepidermal alterationsS B Smith, T J Harrist, G F Murphy, et al.

Journal of the American Academy of Dermatology|April 1, 1991

Systematic underreporting of cutaneous malignant melanoma in Massachusetts. Possible implications for national incidence figuresH K Koh, R W Clapp, J M Barnett, et al.

Annals of Surgery|July 1, 1981

Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fatC L Day, T J Harrist, F Gorstein, et al.

The Journal of Experimental Medicine|June 1, 1996

Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivoJ J Costa, G D Demetri, T J Harrist, et al.

Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:

Pageof 7

The Journal of Investigative Dermatology|November 1, 1983

Lymphocyte subsets and Langerhans cells/indeterminate cells in erythema multiformeR J Margolis, M G Tonnesen, T J Harrist, et al.

American Journal of Clinical Pathology|March 1, 1983

Histiocytosis-X: in situ characterization of cutaneous infiltrates with monoclonal antibodiesT J Harrist, A K Bhan, G F Murphy, et al.

The Journal of Investigative Dermatology|May 1, 1995

Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiformeL F Brown, T J Harrist, K T Yeo, et al.

Circulation|January 11, 2000

Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?M H Rubenstein, L C Harrell, B V Sheynberg, et al.

The American Journal of Cardiology|March 29, 2001

Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failureM H Rubenstein, B V Sheynberg, L C Harrell, et al.

JAMA|September 3, 1982

Skin lesions suspected to be melanoma should be photographed. Gross morphological features of primary melanoma associated with metastasesC L Day, M C Mihm, A J Sober, et al.

Archives of Dermatology|March 1, 1984

Linear IgA bullous dermatosis v dermatitis herpetiformis. Quantitative measurements of dermoepidermal alterationsS B Smith, T J Harrist, G F Murphy, et al.

Journal of the American Academy of Dermatology|April 1, 1991

Systematic underreporting of cutaneous malignant melanoma in Massachusetts. Possible implications for national incidence figuresH K Koh, R W Clapp, J M Barnett, et al.

Annals of Surgery|July 1, 1981

Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fatC L Day, T J Harrist, F Gorstein, et al.

The Journal of Experimental Medicine|June 1, 1996

Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivoJ J Costa, G D Demetri, T J Harrist, et al.

Pageof 7